Rewards abound with an app that provides a Loyalty Love-In for the investment market.

My computer screen saver has a “Join Microsoft Rewards” program that promises me value. Win points, secure rewards, it’s a win-win. But this loyalty love-in game is a hard one to win, unless of course, you have the team, the technology, and are proving that you can build an online community with trust?

Who does this in today’s day and age when many of us have quit visiting sites that require username and passwords, understanding the algorithms of data collection and associated artificial intelligence may or may not be our friend? Global Cannabis Applications Corp.’s (“GCAC”) (CSE: APP | OTCQB: FUAPF) Brad Moore has identified this formula by doing what no other reward program does through the Citizen Green Community, and will pay us like no other for our data.

The investor I had breakfast with this morning said to me: “You know Tracy, everyone is an investor nowadays — they want to buy stock on Friday and sell it on Monday.”

Not a licensed investment advisor, so this is not a buy recommendation, but having been in the public markets since 2001, I, like many in our audience, am a self-directed investor and want to see my money grow. So count me in, as 1 of the 650,000 members and climbing of Citizen Green.

Over the years we have seen many companies whose share price seems undervalued. And to make this column more interesting, I decided to go on record with my interest in GCAC and buy CAD$2500 worth of Global Cannabis Applications’ CSE: APP. The plan? Hold it for 12-weeks, and let you know what I sell it for. Let me be clearer. Today, I bought 15,000 shares of $APP.C at CAD$0.165 for a total of $2475 which I will sell on February 14, 2019.

So why Global Cannabis Applications Corp. or GCAC as many refer to it?

For me, I always have my interest engaged by the leadership and in this case, it was the CEO Brad Moore’s engaging and data building plan-of-action when he said in his last ii-interview with me: “We are basically building the smartest budtender in the world”.

“I like their Citizen Green platform because of the information.” Starts our Social Media Director Sharron Clayton. Then she goes on to add: “The database is very informative. Basically, it takes all the guess work out of how to select what medical cannabis is right for each patient.”

Is this why they use the trading symbol “APP”? I asked our production manager Sam Markham who has a real handle on the cannabis market on our team and to whom we regularly consult with. Not impressed with my witticism, he explained that GCAC’s Citizengreen.io platform creates a loyalty program that covers the industry and is not tied to a single location, giving customers the ability to still be part of the “community” without being tied to a single store, expanding GCAC’s reach.

If you think about it, when have we ever received loyalty points for buying prescriptions? Better yet, Sam in our team tells me we get points for providing follow-up reviews of the prescription. With incentive for community interaction through the reward of Citizen Green Coins or CGC’s, GCAC is collecting valuable information for the medical market and data towards helping in the management of every cannabis “pain to strain” issue and enhancing our life experience.

But consider? If the Citizengreen.io platform can do it right for the cannabis market, as Matt Bohlsen wrote a week ago become the “world’s first end-to-end – from patient to regulator – medical cannabis data solution” is there any reason this might not step over the cannabis medical wall and right into the lap of the global medical market? Now in this future hypothetical scenario, the $APP.C shareholder would be the “citizen in the green”…

On a final note, we reviewed some highlights on CSE: APP this morning that we thought we might share with you —

  1. History. Past price activity has shown acceptance by market to higher market cap (REF: Traded in 01/18 @.99 per share or 5x current mkt value)
  2. Trading. Trades on both CDN and US stock Exchanges (CSE: APP | OTCQB: FUAPF) for investor access
  3. Sponsorship. Good broker sponsorship (Trapeze Capital Corp EST 1999)
  4. Market Cap. Current Low market cap offers price opportunity with manageable share float. (Current Mkt Cap about $11.5 million/57.5 million shares outstanding.)
  5. Volume. Trades enough daily share volumes for long- and short-term investors. (Average daily volume 300k shares)

We also liked the overview on the Citizen Green Platform written by InvestorIntel’s Matt Bohlsen in a story titled The world’s first end to end, from seed to sale, patient to regulator, medical cannabis data solution is here

The Citizen Green platform is the world’s first end to end, from seed to sale, patient to regulator, medical cannabis data solution. It uses 6 core technologies: mobile applications, artificial intelligence, smart databases, blockchain and digital reward tokens; all designed to speed the process of quality shared data. The objective is to use advanced technology to create an online community portal. Every cannabis strain affects patients in a different way, and this is about sharing personal knowledge across a social media style platform to inform other members of personal experiences. By joining the Citizen Green community a medicinal user can now find more information on their particular condition through other users experiences and learn how best to treat it. Transactions and earnings will be in the form of “Citizen Green Token”, GCAC’s cryptocurrency. Citizen Green Tokens, which fuel the Citizen Green economy, are earned for contributing information, and experiences and can be used to receive discounts on purchases and access a full range of related services. There is even a Citizen Green phone app, which as of Q2 2018 already had 650,000 users. GCAC plans to more than double the number of users by Q2 2019 to reach 1.4m global users.

If you missed last week’s interview, GCAC to Sponsor MJBizCon 2018 in Las Vegasclick here




The world’s first end to end, from seed to sale, patient to regulator, medical cannabis data solution is here.

Secondary industries can quite often do surprisingly well as often there is less competition. Global Cannabis Applications Corp. (CSE: APP | OTCQB: FUAPF) (“GCAC”) is a global leader in designing, developing, marketing and acquiring innovative data technologies for the cannabis industry. They are doing this by applying artificial intelligence, blockchain, and cryptocurrency to improve cannabis health sciences, under their Citizen Green platform.

Citizen Green

The Citizen Green platform is the world’s first end to end, from seed to sale, patient to regulator, medical cannabis data solution. It uses 6 core technologies: mobile applications, artificial intelligence, smart databases, blockchain and digital reward tokens; all designed to speed the process of quality shared data. The objective is to use advanced technology to create an online community portal. Every cannabis strain affects patients in a different way, and this is about sharing personal knowledge across a social media style platform to inform other members of personal experiences. By joining the Citizen Green community a medicinal user can now find more information on their particular condition through other users experiences and learn how best to treat it. Transactions and earnings will be in the form of “Citizen Green Token”, GCAC’s cryptocurrency. Citizen Green Tokens, which fuel the Citizen Green economy, are earned for contributing information, and experiences and can be used to receive discounts on purchases and access a full range of related services. There is even a Citizen Green phone app, which as of Q2 2018 already had 650,000 users. GCAC plans to more than double the number of users by Q2 2019 to reach 1.4m global users.

New Citizen Green Website launched

October 2018 was a busy month for GCAC. They announced a major marketing and sales campaign starting October 31, 2018, targeting medical cannabis dispensaries across North America, through their Citizengreen.io website. The new website will have all the information necessary for medical cannabis retailers to learn about the smart technology driven Citizen Green Community. The website is part of an aggressive marketing and sales campaign to introduce the Citizen Green Community to all medical cannabis retailers starting with over 3,300 retail dispensaries with the majority located in California, Colorado, and Arizona.

Brad Moore, CEO of GCAC, stated: “We are launching the Citizengreen website to support our marketing and sales efforts of the Citizen Green Community to thousands of medical cannabis retailers in the United States.”

Previously in October the Company announced it had signed a letter of intent with Cannact LLC, a seasoned distributor of cannabis technology and products in California. The license agreement will integrate the Citizen Green patient-care solution onto Cannact’s platform with potential integration for related cannabis retailer partners. The Cannact team has established relationships with over fifty retail partners and dispensaries.

CEO Brad Moore added: “Cannact is the first of many licensed producers and dispensaries who will seek Citizen Green’s innovated solutions to improve health, safety and patient outcomes in the cannabis industry.”

GCAC has also launched its innovative Citizen Green patient-care solution to the global cannabis marketplace, starting with California which is experiencing explosive growth.

The chart above shows the Company’s achievements to date and targets ahead, including reaching $1M per month in revenue by Q4 2018. GCAC are tapping into the multi-billion-dollar global cannabis industry, where a lack of trusted cannabis related information is yet to exist. Multiple jurisdictions around the world have legalized or are moving toward legalization of medical use including Australia, Canada, Chile, Colombia, Czech Republic, Israel, Mexico and 30 other U.S. states. Having partnerships with leading sources of consumer and medical data could see Global Cannabis Applications Corp. becoming a pioneer in the medical cannabis data storage area. Keep an eye on this social media style business (CannaBook?) (Fannabis?), as their marketing strategies are on track for bigger things to come.




Move over Fantasy Football, the Cannabis Market just got very real.

Forget the Fall sport season because if you haven’t been watching the Cannabis Breakfast Club, we have some awe-inspiring numbers that may get you on-side and looking at stock charts with your morning coffee. Yesterday, we published To be a Billionaire or not? The Canadian Cannabis Breakfast Club struggles with U.S. border entry concerns where we address the significant challenges arising from border crossing concerns for Canadian executives and investors alike entering the U.S.

Speaking of entry am I the only suffering from the colossal cannabis market envy and interested in whether there is room to still enjoy what appears to be a bud bull market?

While Terry Booth of Aurora Cannabis Inc. (TSX: ACB | OTCQB: ACBFF) had been a client in 2015, I recall attending meetings for financings and listening as bankers would explain why they were not interested in cannabis…. this column is dedicated to all of us that could have, should have but maybe didn’t… and more importantly is it too late?

Wince forward.

If we had bought $100k in Aurora Cannabis stock on January 2, 2015 at $0.40, as of market close last night at $10.87, our stock would be worth $2,717,500.

Taking one more step backwards into the past, imagine that we had invested this same fantasy $100k in the 4 leaders in the Canadian Cannabis Breakfast Club in 2015…. what may we have been worth this morning?

Let’s break it down.

Hypothetically, we would have bought 12,195 shares of Canopy Growth Corporation (TSX: WEED) at $2.05, which closed at $63.40 today, market cap $14.5B – and acquired 62,500 shares of Aurora Cannabis Inc. (TSX: ACB) at $0.40, they closed at $10.87 today, market cap $10.35B. Then perhaps we would have selected 23,810 shares of Aphria Inc. (TSX: APH) at $1.05, they closed at $19.28 today, market cap $4.48B. And finally, scoring 31,646 shares of Cronos Group Inc. (TSX: CRON) at $0.79, they closed at $16.25 – market cap $2.87B. And voila, our fantasy 100k would be today worth nearly $2.5M this morning ($2,426,574.00) — a stunning 2326.57% lift in 33 months!

Wow.

Now where are we today? I ask an the CEO of CannaIncome Fund Arthur Kwan – is it too late? He responds: “With Tilray (NASDAQ: TLRY) reaching an intra-day high of US$300 and closing at US$214 today, the mass hysteria surrounding cannabis stocks continues. With a market capitalization of US$20 billion, it is hard to fathom that Tilray, in a matter of a few short months since going public, is now larger than Canopy Growth (TSX: WEED) and other well-known brands, including WhirlPool, Harley-Davidson, and Hyatt Hotels.

While there is no doubt that this is a very over-heated market, we continue to believe that there’s value in this sector, although now you may have to dig a little harder to find that hidden gem. We see opportunities in the next ‘wave’ of growth companies as we get closer to legalization in Canada including edibles, beverages, and biosynthesis.”

He tells me that CannaIncome is maintaining their market advantage by “investing in the early pre-IPO rounds at significant discounts to public company valuations.”

InvestorIntel Editor Matthew Bohlsen provided us with the following updates on half a dozen cannabis sector companies that are advertisers on InvestorIntel. The companies are listed by market cap, these numbers were taken from TD Waterhouse on September 20, 2018.

WeedMD Inc. (TSXV: WMD), $228.04M Market Cap: WeedMD Inc. is a Canadian licensed producer and distributor of cannabis with large production facilities in Canada. The Company recently announced it has completed the export of its cannabis genetics to Australia’s Medifarm.

Edward Harris, Managing Director of Medifarm, said: “Medifarm prides itself on the cultivation of exclusive cannabis genetics, supported by proven breeding programs used in university and hospital clinical trials for therapeutic use. WeedMD’s highly regarded cannabis strains will help us bring Australians continued access to a diverse set of consistent, quality cannabis products, ensuring that our patients have access to clinically validated and cost-effective medicine for their therapeutic use is paramount for Medifarm.”

Early in September 2018, WeedMD announced it has now completed the first harvest from its modern greenhouse in Strathroy, Ontario. The Company marked the event with a WeedMD “First Harvest” celebration party, a community open house that welcomed well over 120 guests that included WeedMD’s Board of Directors, local government, business leaders, investors, media representatives and employees.

Keith Merker, CEO of WeedMD said: “We’re proud to have been able to share this important milestone with our community, stakeholders, employees and industry. The first harvest was completed in early September and resulted in an impressive yield from our first 10,000 square foot grow room.”

I am guessing it must have been a great party, and I hope to get an invitation to the next one as this WeedMD is having great success both in Canada and soon in Australia.

Scythian Biosciences Corp. (CSE: SCYB | OTC – Nasdaq Intl: SCCYF), $173.9M Market Cap: Scythian Biosciences Corp. is an international cannabis company with a focus on the burgeoning U.S. medical cannabis marketplace. Its strategic investments and partnerships across cultivation, distribution and retail complement the company’s R&D program with the University of Miami. It is this comprehensive approach that is positioning Scythian as a future frontrunner in the United States’ medical cannabis industry.

Scythian has initiated its international expansion by launching additional cannabis related activities across the globe. The Company is evaluating several strategic initiatives and pursuing partnerships with local cultivators, pharmaceutical import and distribution entities and universities in North America, South America, Caribbean and beyond.

Just as any area of the body begins to swell after impact and injury due to inflammation, brain tissue itself does as well. Unfortunately, because the brain is confined inside the skull, the inflammation naturally triggered ends up causing even more damage as the process continually pushes already-injured brain tissue against bone. For contact sports players, repeated concussions can have devastating effects later in life. Cannabinoids are an effective treatment for mild brain trauma (concussions). This is going to be great news for professional sports organizations involved in contact sports and should hopefully lead to wide spread adoption for Scythian’s therapy and products.

Viridium Pacific Group Ltd. (TSXV: VIR), $44.82M Market Cap: Viridium Pacific Group Ltd. is a Canadian producer of medical cannabis products. It is proceeding to meet the health Canada requirements to amend its current producer license to include a license to sell. The Company is involved in consumer wellness and biotech innovation, with interests spanning across agricultural production, property development, and financial services.

Viridium Pacific is positioned to develop and expand into new markets across multiple platforms. Earlier this year, a subsidiary of Viridium, Experion Bio-technologies acquired 25 new cannabis strains from a renowned Dutch supplier, increasing the number of strains available from 2 to 27. The new cannabis strains acquired by Experion are proprietary strains developed in one of the most sophisticated breeding programs in the world.

Viridium has signed a Letter of Intent (September 13, 2018) with Montreal Medical Cannabis Inc. (“MMCI”) to establish a partnership in Pointe Claire, Quebec. With only 9 of 116 Canadian license producers headquartered in the province, Quebec represents a significant opportunity for Viridium to establish licensed cannabis cultivation and distribution. Viridium Pacific will provide expertise to help prepare the MMCI facility for Health Canada inspections, and expedite the application process under its licensed subsidiary, Experion Biotechnologies Inc. The facility currently under renovation is 76,000 square feet with an anticipated output of cannabis over 10,000 kg per year. On October 17, 2018, Canada is to become the third nation in the world to formally legalize cannabis for recreational use and become the first G7 nation to do so. Viridium are in a perfect position in a fast-growing industry with new legislation ready to take effect.

NanoSphere Health Sciences Inc. (CSE: NSHS) Market Cap $37.66M: NanoSphere Health Sciences Inc.’s Evolve Formulas product is the provider of the world’s first and only scientifically proven nano particle delivery system for cannabis. For those that can remember the original Star Trek series, the Evolve product administers directly into the system in a similar way to the Doctor on the Enterprise administered medicine. They called it a hypo-spray. This cutting edge technology eliminates the need for inhalation or ingestion of cannabis, offering users a safer and more effective method of consumption.

The onset time of cannabinoids delivered by the NanoSphere Delivery System™ is just 10 minutes, thereby relieving the user from pain and anxiety in an extremely short period of time. NanoSphere was recognized as Company of the Year for Nano Biotechnology and Innovative, Company of the Year for Healthcare, and three 2018 Global Awards from ACQ5, a premier global corporate magazine. NanoSphere has partnered with Delta 9 Cannabis INC to bring products from its cannabis brand, Evolve Formulas, into the Canadian market, under an agreement, that will see a 50/50 net revenue share from sale of Evolve Formulas products.

The NanoSphere Delivery System could be an ideal way to deliver vitamins, minerals, super-nutrients into the system as well as eliminate the use for needles to deliver medicines. That’s got to make parents and kids very happy.

Global Cannabis Applications Corp. (CSE: APP | OTCQB: FUAPF), $20.22M Market Cap: Global Cannabis Applications Corp.  (“GCAC”) goal is to build a technology-enabled community to improve the health and wellness of medical patients and users alike. The Company has created the Citizen Green Community, a database that uses a mobile app platform for subscribers to interact with other medicinal cannabis users to share benefits, knowledge and personal experiences from their use.

Their Prescriptii app is designed to help patients find the appropriate products for their medical condition. It allows patients to easily rate the cannabis products they have been prescribed, learn about products that have helped other patients, and provide feedback about the effectiveness.

The Company’s CannaLife app was designed to create conversation, share ideas, and promote education on a single social platform (the Cannabis Facebook?). Real conversations will take place showing users what is trending, who to follow, tag, subscribe, and communities to join. Users can also lead the conversation by creating their own communities or sharing information by taking a snapshot from a web page.

With the Prescriptii and CannaLife apps, and the Citizen Green data platform, GCAC is establishing a leadership position by using science and advance technology to gain important insight into the medical cannabis industry. Because of legislation, data on cannabis use and its effects hasn’t really existed for obvious reasons (who wanted it known that you were a user). Now GCAC is giving medicinal users the chance to record and share experiences on the Company’s Citizen Green apps.

CO2 GRO Inc. (TSXV: GROW), $10.62M Market Cap: CO2 GRO Inc.’s (“GROW”) mission is to accelerate all outdoor and indoor plants naturally, safe and economically using its patented advanced CO2 foliar spray technologies. Recent trials are proof of this, with results on CO2 foliar spray versus CO2 gassing. Spraying dissolved CO2 to the top as well as the bottom of a lettuce leaf is more effective in stimulating dramatically faster plant growth and plant size/mass than CO2 gassing. This also proves why GROW’s CO2 Foliar Spray technology integrated into advanced irrigation boom trials are showing sharply faster and larger plant growth.

CEO John Archibald noted: “This additional St. Cloud State University discovery and success integrating our CO2 technology into irrigation spray booms provides further evidence of the commercial potential of our technology. Our revenue generation model is long term site technology licenses and lease of our integration equipment in both indoor and outdoor boom spray systems.”

In August, CO2 GRO conducted their second cannabis trial with a positive commercial indoor trial. The second trial was on a leafier indicia strain that yielded an estimated 60% increase in bud value whereas the first trial on a stringier sativa strain yielded an estimated 45% increase. CO2 GRO’s Indica cannabis trial bud weight increased 20%, was grown 20% faster and had 75% more THC than the control bud group.

It is kind of amazing when you think how this could possibly solve food shortage problems and create a stronger cannabis strain. More food is going to be needed globally each year, and CO2 GRO can play an important role.




Cannabook? The “Data-Crypto Facebook App” of Global Cannabis

The oldest known written record on cannabis use comes from the Chinese Emperor Shen Nung in 2727 B.C. Ancient Greeks and Romans were also familiar with cannabis, while in the Middle East, use spread throughout the Islamic empire to North Africa. In 1545 cannabis spread to the western hemisphere where Spaniards imported it to Chile for its use as fiber. In North America cannabis, in the form of hemp, was grown on many plantations for use in rope, clothing and paper. Entering the 21st century, some nations have begun to change their approaches, with measures taken to decriminalize cannabis. In 2001 Canada became the first nation to legalize medical cannabis, and then in 2015 Uruguay became the first to legalize recreational cannabis. On October 17 2018, Canada will follow Uraguay to become only the second country to legalize recreational cannabis.

Recreational cannabis becomes legal in Canada starting October 17, 2018

Global Cannabis Applications Corp. (CSE: APP | OTCQB: FUAPF) (“GCAC”) designs, develops, markets, and acquires data technologies for the cannabis industry by applying artificial intelligence, blockchain, and crypto-currency to improve cannabis health sciences. The Company’s mission is to build a technology-enabled community to improve the health and wellness of medical patients and users, through data optimization of medical cannabis research and production. The Company offers the “Citizen Green” platform, an end-to-end data aggregation and user delivery system. The Citizen Green platform is the world’s first end-to-end, from seed to sale, to patient, to regulator, medical cannabis data solution. It uses 6 core technologies: mobile applications, artificial intelligence, smart databases, blockchain and digital reward tokens, all designed to speed the process of quality data and provide better qualified candidates for clinical studies.

Cryptocurrency and Cannabis working together

The true objective of the Citizen Green platform is to use advanced technology to create an online community portal, where patient outcomes can be improved through the sharing and use of medical cannabis information. As the global community grows and the database builds, the platform will become more efficient by gathering data from all points of the cannabis community. By joining the Citizen Green community a medicinal user can now find more information on their particular condition through other users experiences, and learn how best to treat it.

On 1 August 2018, the Company announced that in Q2 2018 they achieved 415,000 new downloads of their CannaLife app. The app runs on a social media platform building online global communities as well as a propriety search engine with intuitive posting and asynchronized video chat. Hanan Gelbendorf, GCAC’s chief marketing officer stated: “This is a significant milestone as we roll out the Citizen Green Community and its digital assets in an effort to improve the lives of medical cannabis patients.”

Transactions and earnings will be in the form of a “Citizen Green Token,” GCAC’s cryptocurrency. The tokens will be the basis of a loyalty program and will be used to reward users, pay for additional databases, facilitate research and development, and advance the technological platform. Citizen Green Tokens, which fuel the Citizen Green economy are earned for contributing information and experiences and can be used to receive discounts on purchases and access a full range of related services.

The global legal marijuana market is forecast to reach USD 146.4 billion by the end of 2025, and grow at a CAGR of 34.6%. With more markets joining the medical cannabis revolution the importance and value for data and information on medical cannabis performance has never been greater. With over forty two governments globally moving forward with the legalization of medical cannabis, there is a need and an opportunity to fill the medical cannabis data void using advanced technology. Global Cannabis Applications aims to fill this void, and just may become the “Data-Crypto Facebook App” of global cannabis. (Cannabook?)

Global Cannabis Applications Corp. has a market cap of C$ 19 m, and is headquartered in Vancouver Canada.




Global Cannabis Applications CEO on the blockchain technology that is changing the face of the medical cannabis market

Brad Moore, CEO and Director of Global Cannabis Applications Corp. (CSE: APP | OTCQB: FUAPF) (“Global Cannabis”), a global leader in designing, developing, marketing, and acquiring innovative mobile applications in the medical cannabis sector; in an interview with InvestorIntel Senior Editor Jeff Wareham discuss their Citizen Green platform. The Citizen Green platform uses blockchain, artificial intelligence and mobile technologies to help regulators and regulatory medical programs around the world find a faster way to locate high quality regulated cannabis products. Brad explains what investors can expect to hear in next 90 days from Global Cannabis – wanna hear more?…to access the complete interview, click here

Disclaimer: Global Cannabis Applications Corp. is an advertorial member of InvestorIntel Corp.